Affimed (AFMD) Competitors

BioCardia (NASDAQ:BCDA) and Affimed (NASDAQ:AFMD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

Do analysts prefer BCDA or AFMD?

BioCardia currently has a consensus price target of $25.00, indicating a potential upside of 986.96%. Affimed has a consensus price target of $7.90, indicating a potential upside of 4,251.52%. Given Affimed's higher probable upside, analysts plainly believe Affimed is more favorable than BioCardia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioCardia	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Affimed	0 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.14

Which has more risk and volatility, BCDA or AFMD?

BioCardia has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Affimed has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500.

Is BCDA or AFMD more profitable?

BioCardia has a net margin of -1,999.77% compared to Affimed's net margin of -7,836.26%. BioCardia's return on equity of 0.00% beat Affimed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioCardia	-1,999.77%	N/A	-208.38%
Affimed	-7,836.26%	-193.84%	-107.24%

Does the media prefer BCDA or AFMD?

In the previous week, BioCardia and BioCardia both had 2 articles in the media. BioCardia's average media sentiment score of 1.43 beat Affimed's score of 0.00 indicating that BioCardia is being referred to more favorably in the media.

Company	Overall Sentiment
BioCardia	Positive
Affimed	Neutral

Which has higher valuation and earnings, BCDA or AFMD?

BioCardia has higher earnings, but lower revenue than Affimed.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioCardia	$3K	3,969.80	-$11.57M	-$2.33	-0.99
Affimed	$877K	3.33	-$114.66M	N/A	N/A

Do institutionals and insiders hold more shares of BCDA or AFMD?

20.6% of BioCardia shares are held by institutional investors. Comparatively, 30.8% of Affimed shares are held by institutional investors. 20.0% of BioCardia shares are held by company insiders. Comparatively, 3.8% of Affimed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in BCDA or AFMD?

Affimed received 422 more outperform votes than BioCardia when rated by MarketBeat users. Likewise, 68.92% of users gave Affimed an outperform vote while only 60.71% of users gave BioCardia an outperform vote.

Company	Underperform	Outperform
BioCardia	Outperform Votes 17 60.71%	Underperform Votes 11 39.29%
Affimed	Outperform Votes 439 68.92%	Underperform Votes 198 31.08%

Summary

BioCardia beats Affimed on 8 of the 15 factors compared between the two stocks.